DPP4 and heart failure: Additionally, a recent meta-analysis concluded that, despite an abundance of low-quality evidence, DPP4 inhibitors ‘may increase the risk of hospital admission for heart failure in those patients with existing CVD or multiple risk factors for vascular diseases, compared with no use’.72